Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to $97.4 million.

  • Cresco Labs' Total Current Liabilities fell 3859.27% to $97.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.4 million, marking a year-over-year decrease of 3859.27%. This contributed to the annual value of $94.3 million for FY2024, which is 5288.8% down from last year.
  • As of Q3 2025, Cresco Labs' Total Current Liabilities stood at $97.4 million, which was down 3859.27% from $101.3 million recorded in Q2 2025.
  • Cresco Labs' 5-year Total Current Liabilities high stood at $331.2 million for Q1 2022, and its period low was $94.3 million during Q4 2024.
  • For the 5-year period, Cresco Labs' Total Current Liabilities averaged around $207.9 million, with its median value being $218.7 million (2021).
  • In the last 5 years, Cresco Labs' Total Current Liabilities skyrocketed by 2930.91% in 2022 and then crashed by 5288.8% in 2024.
  • Over the past 5 years, Cresco Labs' Total Current Liabilities (Quarter) stood at $288.4 million in 2021, then decreased by 11.28% to $255.9 million in 2022, then decreased by 21.74% to $200.2 million in 2023, then tumbled by 52.89% to $94.3 million in 2024, then grew by 3.22% to $97.4 million in 2025.
  • Its Total Current Liabilities was $97.4 million in Q3 2025, compared to $101.3 million in Q2 2025 and $113.2 million in Q1 2025.